home / stock / cprx / cprx articles

CPRX Articles, Catalyst Pharmaceuticals Inc.

Stock Information
Company Name: Catalyst Pharmaceuticals Inc.
Stock Symbol: CPRX
Market: NASDAQ
Website: catalystpharma.com
Menu
CPRX CPRX Quote CPRX Short CPRX News CPRX Articles CPRX Message Board
Get CPRX Alerts

News, Short Squeeze, Breakout and More Instantly...
Insider Transaction: Jeffrey Del Carmen Sells $121K Worth Of Catalyst Pharmaceuticals Shares | Benzinga

Jeffrey Del Carmen, Chief Commercial Officer at Catalyst Pharmaceuticals (NASDAQ:CPRX), executed a substantial insider sell on June 11, according t...
Catalyst Pharmaceuticals Board Member Sold $86K In Company Stock | Benzinga

Revealing a significant insider sell on June 5, Molly Harper, Board Member at Catalyst Pharmaceuticals (NASDAQ:CPRX), as per the latest SEC filing....

Insider Transaction: Richard J Daly Sells $276K Worth Of Catalyst Pharmaceuticals Shares | Benzinga

Richard J Daly, President and CEO at Catalyst Pharmaceuticals (NASDAQ:CPRX), executed a substantial insider sell on June 5, according to an SEC fil...

Catalyst Pharmaceuticals to Participate at the Jefferies Global Healthcare Conference 2024 | Benzinga

CORAL GABLES, Fla., May 28, 2024 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. ("Catalyst" or "Company") (NASDAQ:CPRX), a ...
Catalyst Pharmaceuticals to Participate at the BofA Securities Health Care Conference 2024 | Benzinga

CORAL GABLES, Fla., May 01, 2024 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. ("Catalyst" or "Company") (NASDAQ:CPRX), a ...

Catalyst Pharmaceuticals Announces Support for the Inaugural Lambert-Eaton Myasthenic Syndrome (LEMS) Awareness Day | Benzinga

CORAL GABLES, Fla., March 28, 2024 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. ("Catalyst") (NASDAQ:CPRX), a commercial-stage, pa...

Catalyst Pharmaceuticals to Participate in the 2024 Cantor Virtual Muscular Dystrophy Symposium | Benzinga

CORAL GABLES, Fla., March 27, 2024 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. ("Catalyst") (NASDAQ:CPRX), a commercial-stage bio...
Catalyst Pharmaceuticals to Participate at the Barclays 26th Annual Global Healthcare Conference | Benzinga

CORAL GABLES, Fla., March 05, 2024 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. ("Catalyst" or "Company") (NASDAQ:CPRX), ...

Top 3 Health Care Stocks You May Want To Dump In Q1 | Benzinga

As of Feb. 29, 2024, three stocks in the health care sector could be flashing a real warning to investors who value momentum as a key criteria in t...

Catalyst Pharmaceuticals Reports Strong Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update | Benzinga

    Achieved Record 2023 Total Revenues of $398.2 Million, an 85.9% Increase Compared to 2022 Achieved Record Fourth Quarter 2023 Total Revenu...
Next 10